Tuesday, October 21, 2014
| 8:00 a.m. – 8:45 a.m. | Registration & Networking Breakfast Buffet |
| 8:45 a.m. – 9:00 a.m. | Welcome
Debbie Hart, President and CEO, BioNJ |
| 9:00 a.m. – 9:45 a.m. | Keynote
Geno Germano, Group President, Global Innovative Pharma Business, Pfizer Inc. |
| 9:45 a.m. – 10:00 a.m. | Presenting Company
Adam Grossman, President and CEO, ADMA Biologics, Inc. |
| 10:00 a.m. – 10:45 a.m. | Diving Deeper Into Outsourcing
Michael Griffith, Executive Vice President, inVentiv |
| 10:45 a.m. – 11:00 a.m. | Break |
| 11:00 a.m. – 11:45 a.m. | Charting the Right Path; Finding the Good Footholds
Chris Garabedian, President and CEO, Sarepta Therapeutics |
| 11:45 a.m. – 12:30 p.m. | Finding Fertile Ground in the Financial Markets
Al Altomari, President, CEO and Director, Agile Therapeutics, Inc. |
| 12:30 p.m. – 1:15 p.m. | Creating a Patient Focused Culture of Excellence
Mark J. Alles, President and Chief Operating Officer, Celgene Corporation |
| 1:15 p.m. – 2:30 p.m. | Luncheon & Keynote
Christi Shaw, US Country Head, President, Novartis Corporation and President, Novartis Pharmaceuticals Corporation |
| 2:30 p.m. – 3:30 p.m. | Closing Remarks & Dessert Networking Reception |
By Invitation Only: BioNJ Board of Trustees, Speakers, Executive Suite Sponsors and Committee of Volunteers
Monday, October 20, 2014
| 6:00 p.m. – 7:00 p.m. | Networking Reception |
| 7:00 p.m. – 9:00 p.m. | Welcome
Francois Nader, M.D., President, CEO and Director, NPS Pharmaceuticals Fireside Chat Frank Hatheway, Ph.D., Chief Economist, NASDAQ OMX Group Inc. |